- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2024 · Mar 31, 2024 | $2.26K |
| Capex | Q1 2024 · Mar 31, 2023 | $10.76K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.67M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$1.47M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $31.41K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $2.14M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$28.33M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$27.19M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$5.29M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$793.89K |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2021 | −$793.89K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $28.53M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $26.53M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $29.26M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $28.64M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $669.25K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $1.16M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $922.61K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.44M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.16 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.69 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.69 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $919.8K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $3.61M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $945.13K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $599.23K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$2.5M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$4.36M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$2M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$4.32M |